|
|
|
|
LEADER |
03199nam a2200313Ia 4500 |
001 |
10.1186-s12885-022-09519-y |
008 |
220706s2022 CNT 000 0 und d |
020 |
|
|
|a 14712407 (ISSN)
|
245 |
1 |
0 |
|a Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) cancer survivor health: program project protocols for remote lifestyle intervention and assessment in 3 inter-related randomized controlled trials among survivors of obesity-related cancers
|
260 |
|
0 |
|b BioMed Central Ltd
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1186/s12885-022-09519-y
|
520 |
3 |
|
|a Background: Scalable, multiple behavior change interventions are needed to address poor diet, inactivity, and excess adiposity among the rising number of cancer survivors. Efficacy-tested diet (RENEW) and exercise (BEAT Cancer) programs were adapted for web delivery among middle-aged and older cancer survivors for the AMPLIFI study, a National Cancer Institute-funded, multi-site, program project. Methods: Throughout the continental U.S., survivors of several obesity-related cancers are being recruited for three interconnected randomized controlled trials (RCTs). Projects 1 and 2 test 6-month diet or exercise interventions versus a wait-list control condition. Upon completion of the 6-month study period, the intervention participants receive the next behavior change sequence (i.e., diet receives exercise, exercise receives diet) and the wait-list control arm initiates a 12-month combined diet and exercise intervention. Project 3 tests the efficacy of the sequential versus simultaneous interventions. Assessments occur at baseline and semi-annually for up to 2-years and include: body mass index, health behaviors (diet quality, accelerometry-assessed physical activity/sleep), waist circumference, D3 creatine-assessed muscle mass, physical performance, potential mediators/moderators of treatment efficacy, biomarkers of inflammation and metabolic regulation, health care utilization, cost, and overall health. Four shared resources support AMPLIFI RCTs: 1) Administrative; 2) Adaptation, Dissemination and Implementation; 3) Recruitment and Retention; and 4) Assessment and Analysis. Discussion: Representing a new generation of RCTs, AMPLIFI will exclusively use remote technologies to recruit, intervene and assess the efficacy of the newly-adapted, web-based diet and exercise interventions and determine whether sequential or combined delivery works best for at-risk (older, rural, racial minority) cancer survivors. Trial registration: ClinicalTrials.gov, NCT04000880. Registered 27 June 2019. © 2022, The Author(s).
|
650 |
0 |
4 |
|a Cancer
|
650 |
0 |
4 |
|a Diet
|
650 |
0 |
4 |
|a Older adults
|
650 |
0 |
4 |
|a Physical activity
|
650 |
0 |
4 |
|a Physical function
|
650 |
0 |
4 |
|a Survivorship
|
700 |
1 |
0 |
|a Demark-Wahnefried, W.
|e author
|
700 |
1 |
0 |
|a Fontaine, K.
|e author
|
700 |
1 |
0 |
|a Ivankova, N.V.
|e author
|
700 |
1 |
0 |
|a Kenzik, K.
|e author
|
700 |
1 |
0 |
|a Martin, M.Y.
|e author
|
700 |
1 |
0 |
|a Oster, R.A.
|e author
|
700 |
1 |
0 |
|a Pekmezi, D.
|e author
|
700 |
1 |
0 |
|a Pisu, M.
|e author
|
700 |
1 |
0 |
|a Rogers, L.Q.
|e author
|
700 |
1 |
0 |
|a Schoenberger-Godwin, Y.-M.
|e author
|
773 |
|
|
|t BMC Cancer
|